Annual Results Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2025 is 9.71% vs 5.56% in Mar 2024
Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods;
Fixed Assets
YoY Growth in year ended Mar 2025 is -2.11% vs 0.37% in Mar 2024
Investments
No Investments in the last few periods;
Current Assets
YoY Growth in year ended Mar 2025 is -41.17% vs 8.59% in Mar 2024
Compare Balance Sheet Results of Krebs Biochem
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
21.56
13.00
8.56
65.85%
Share Warrants & Outstandings
Total Reserve
-167.80
-4.47
-163.33
-3,653.91%
Shareholder's Funds
-146.24
8.53
-154.77
-1,814.42%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
161.25
0.00
161.25
0.00%
Secured Loans
0.00
0.00
0.00
0.00%
Unsecured Loans
161.25
0.00
161.25
0.00%
Deferred Tax Assets / Liabilities
0.00
0.00
0.00
0.00%
Other Long Term Liabilities
45.00
0.00
45.00
0.00%
Long Term Trade Payables
2.44
0.00
2.44
0.00%
Long Term Provisions
3.06
0.00
3.06
0.00%
Total Non-Current Liabilities
211.75
0.00
211.75
0.00%
Current Liabilities
Trade Payables
18.15
0.04
18.11
45,275.00%
Other Current Liabilities
33.63
0.27
33.36
12,355.56%
Short Term Borrowings
50.96
0.00
50.96
0.00%
Short Term Provisions
0.79
0.00
0.79
0.00%
Total Current Liabilities
103.53
0.30
103.23
34,410.00%
Total Liabilities
169.04
8.84
160.20
1,812.22%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
314.11
0.00
314.11
0.00%
Less: Accumulated Depreciation
168.40
0.00
168.40
0.00%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
145.70
0.00
145.70
0.00%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
1.24
0.00
1.24
0.00%
Intangible assets under development
1.85
0.00
1.85
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.00
0.00
0.00
0.00%
Long Term Loans & Advances
9.98
0.00
9.98
0.00%
Other Non Current Assets
0.00
0.00
0.00
0.00%
Total Non-Current Assets
158.78
0.00
158.78
0.00%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
6.03
0.00
6.03
0.00%
Sundry Debtors
0.05
0.00
0.05
0.00%
Cash and Bank
0.14
0.01
0.13
1,300.00%
Other Current Assets
0.47
5.16
-4.69
-90.89%
Short Term Loans and Advances
3.56
3.67
-0.11
-3.00%
Total Current Assets
10.26
8.84
1.42
16.06%
Net Current Assets (Including Current Investments)
-93.27
8.53
-101.80
-1,193.43%
Total Current Assets Excluding Current Investments
10.26
8.84
1.42
16.06%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
169.04
8.84
160.20
1,812.22%
Contingent Liabilities
8.47
0.00
8.47
0.00%
Total Debt
212.21
0.00
212.21
0.00%
Book Value per share (adjusted)
-67.83
6.56
-74.39
-1,133.99%
Annual - Borrowings
Borrowings 212.21 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 9.71% vs 5.56% in Mar 2024
Annual - Other Long Term Liabilities
Other Long Term Liabilities 45.00 Cr
in Mar 2025Figures in Cr
No Other Long Term Liabilities in the last few periods;
Annual - Fixed Assets
Fixed Assets 146.94 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -2.11% vs 0.37% in Mar 2024
Annual - Investments
No Investments in the last few periods
No Investments in the last few periods;
Annual - Current Assets
Current Assets 10.26 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -41.17% vs 8.59% in Mar 2024
